本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
Mauve Group is awarded 'Excellence in Global Mobility, Global Policy Design, or Implementation' at the Think Global People and Relocate Awards. Hosted by Relocate Global, the award ceremony brought together leaders from across the global mobility, relocation, and international management sector. Mauve is proud to announce its 2nd award win of the year to date. LONDON, June 23, 2023 /PRNewswire/ -- Mauve Group is delighted to announce it has been presented with the 'Excellence in Global Mobility, Global Policy Design or Implementation' Award at the Think Global People and Relocate Awards 2023. Announced at The Innovation Festival for Global Working, the award ceremony celebrated the achievements of leading organisations across the global mobility and international relocation sector. During The Innovation Festival for Global Working, Mauve CEO Ann Ellis took part in a keynote panel discussing how the evolution of global trends is impacting diverse industry sectors. Chaired by BAFTA-nominated journalist Jayne Constantinis, Ann was joined by Valérie Besanceney, Executive Director at Safe Passage Across Networks and Demetra Marcantonio, Director of KPMG's Global Mobility Services team. The global mobility accolade accepted by CEO Ann Ellis recognises Mauve's contribution to relocation management, by supporting organisations with global business expansion, overseas mobility projects, and maximising return on investment. The award application discussed the solutions Mauve provides across the Not-for-Profit sector, to showcase how its expertise support businesses with global mobility projects. The application was supplemented by a supporting video and all applications were then scrutinised by a panel of judges. Mauve Group was credited by the judges for its innovative employment solutions and for providing "an inspirational approach for all organisations wishing to operate effectively without jeopardising compliance requirements". CEO Ann Ellis expressed, "Myself and the team are thrilled to receive this award. Gaining recognition for the delivery of excellent global mobility services that prioritise the utmost compliance, enables us to raise our visibility and support more clients globally." This is Mauve's second award win of 2023 to date – a testament to Mauve's authenticity and expertise in an increasingly competitive sector. About Mauve: With over 27 years of experience, Mauve Group is a leading global HR, Employer of Record, and business consultancy solutions provider. Mauve has developed the global knowledge to support businesses of any size planning to expand internationally. For more information, please contact Ellie Simmons, press@mauvegroup.com or visit www.mauvegroup.com.
2023財年第三季度，埃森哲全球營業收入達到166億美元，以美元和當地貨幣計，分別同比增長3%和5%。 第三季度經調整後的營業利潤達27.1億美元；調整後的營業利潤率達16.3%；稀釋每股收益為3.15美元；新訂單額172億美元。 埃森哲預計2023財年全年營收增長在8%至9%之間（以當地貨幣計）。 北京2023年6月23日 /美通社/ -- 埃森哲（紐交所代碼：ACN）最新財務報告顯示， 公司2023財年第三季度（截至2023年5月31日）全球營業收入達到166億美元，以美元和當地貨幣計，分別同比增長3%和5%。 2023財年第三季度經調整後的營業利潤達27.1億美元；調整後的營業利潤率達16.3%；稀釋每股收益為3.15美元；新訂單額為172億美元。 以業務劃分，2023財年第三季度，埃森哲咨詢相關業務貢獻了86.9億美元的收入，托管服務相關業務收入為78.7億美元。以區域市場劃分，包括中國市場在內的成長型市場貢獻了32.3億美元的收入，以當地貨幣計同比增長9%。北美和歐洲區域市場的收入分別為77.2億美元和56.2億美元，以當地貨幣計分別同比增長2%和7%。 埃森哲董事長兼首席執行官沈居麗（Julie Sweet）表示：「公司三季度實現了堅實的新訂單和營業收入，經調整的營業利潤、每股收益和自由現金流十分強勁，表明我們的業務穩健有序。我們致力於成為客戶轉型的最佳夥伴，該戰略繼續獲得市場認可，三季度全球有26個客戶的訂單額達到了1億美元及以上。數十年來，我們的業務模式在廣泛的市場、行業和服務領域建立了優勢，在全球73萬餘名員工的鼎力支持下，能夠持續為客戶和各個利益相關方創造360°價值。」 展望2023財年全年，埃森哲現預計營業收入增長以當地貨幣計將在8%至9%之間；稀釋每股收益預計將在10.94美元至11.05美元之間；全年營業利潤率預計為14.2%。 埃森哲於2023年6月22日（北美東部夏令時間）上午8時召開第三季度財務報告電話會議。自6月22日（北美東部夏令時間）上午11時開始，埃森哲網站accenture.com將提供電話會議的重播，並持續到2023年9月27日。 關於埃森哲 埃森哲公司註冊於愛爾蘭，是一家全球領先的專業服務公司，幫助企業、政府和各界組織構建數字化核心能力、優化運營、加速營收增長、提升社會服務水平，更快且更規模化地創造切實價值。埃森哲是《財富》世界500強企業之一，堅持卓越人才和創新引領，目前擁有約73.2萬名員工，服務於120多個國家的客戶。我們是技術引領變革的全球領軍者之一，擁有強大的生態協作網絡。憑借深厚的技術專長和行業經驗、獨特的專業技能，以及翹楚全球的卓越技術中心和智能運營中心，我們獨樹一幟地為客戶提供戰略&咨詢、技術服務、智能運營、工業X和Accenture Song等全方位服務和解決方案，為客戶創造切實價值。埃森哲致力於通過卓越的服務能力、共享成功的文化，以及為客戶創造360°價值的使命，幫助客戶獲得成功並建立長久信任。埃森哲同樣以360°價值衡量自身，為我們的客戶、員工、股東、合作夥伴與整個社會創造美好未來。 詳細信息，敬請訪問埃森哲公司主頁accenture.com。
Dassault Aviation will use Dassault Systèmes' 3DEXPERIENCE platform on the cloud to develop its next-generation fighter, a key project in the Future Combat Air System The 3DEXPERIENCE platform operated on OUTSCALE provides a dedicated sovereign defense cloud with the highest level of security and continuous software developments This next step in their long-term collaboration is a key driver of a European sovereign cloud that can influence other sectors such as health care and public services LE BOURGET, France, June 23, 2023 /PRNewswire/ -- Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Dassault Aviation (Euronext Paris FR0014004L86, AM.PA) announced at the Paris Air Show, the next step in their long-term collaboration aimed at bringing the highest levels of security, sovereignty and collaboration on the cloud to major defense programs. Dassault Aviation will use Dassault Systèmes' 3DEXPERIENCE platform on the cloud to develop its next-generation fighter, a key project in the Future Combat Air System industrial collaboration to ensure the future of European autonomy and sovereignty in defense and security. This cloud environment will be localized in Dassault Aviation premises and operated by Dassault Systèmes through its OUTSCALE brand, whose SecNumCloud qualification is the highest security recognition given by the National Cybersecurity Agency of France. The 3DEXPERIENCE platform provides a dedicated sovereign defense cloud in which Dassault Aviation and its partners can develop the fighter with greater agility in a highly secured and scalable environment. Users will benefit from continuous software developments by Dassault Systèmes that deliver the latest capabilities in systems engineering, program management, design, simulation and other disciplines. "France and Europe need to build up a sovereign Cloud capability, so that they can develop collaborative defense programs with the best possible functionality. Initiatives are already in place outside Europe. We need to stay in the race. In Europe, we are fortunate to have the world leader in digital solutions for the development of industrial products in the Cloud. For our part, we're an industrial architect, a custodian of sovereignty technologies and experienced in prime contracting for major military programs, both in France and in multinational cooperation. This partnership between Dassault Aviation and Dassault Systèmes provides the first collaborative engineering solution adapted to the cyber regulations required for defense programs, and evolving at the speed of the Cloud," said Eric Trappier, Chairman and CEO, Dassault Aviation. As part of Dassault Aviation's ongoing digital transformation, Dassault Systèmes will also extend this infrastructure to all of Dassault Aviation's new programs, to provide a consistent, secure environment for seamless, compliant programs. "Society today is faced with profound challenges requiring defense programs that can ensure a safer future for citizens. In this context, industry innovators working with highly sensitive data must transform their programs – and how they work with their ecosystems – to secure every phase of development," said Bernard Charlès, Chairman and CEO, Dassault Systèmes. "Today, our ongoing partnership with Dassault Aviation is reaching new heights – positioning us as key actors in the emergence of a European sovereign cloud with the highest level of security. As the strategic, sovereign cloud partner for governments and companies, we can bring the same security in defense to other industries such as health care and public services." Dassault Aviation will rely on the "Winning Concept," "Program Excellence," "Co-Design to Target" and "Ready for Rate" industry solution experiences based on the 3DEXPERIENCE platform, which simplify and streamline the development of highly complex systems and programs to meet budget, schedule and performance targets. Social media: Connect with Dassault Systèmes on Twitter Facebook LinkedIn YouTube For more information: Dassault Systèmes' industry solution experiences for Aerospace and Defense: https://www.3ds.com/industries/aerospace-defense/aerospace-defense-solutions Dassault Systèmes' 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com About Dassault Systèmes Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com © Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. About Dassault Aviation With over 10,000 military and civil aircraft (including 2,700 Falcons) delivered in more than 90 countries over the last century, Dassault Aviation has built up expertise recognized worldwide in the design, development, sale and support of all types of aircraft, ranging from the Rafale fighter, to the high-end Falcon family of business jets, military drones and space systems. In 2022, Dassault Aviation reported revenues of €6.9 billion. The company has 12,700 employees. www.dassault-aviation.com twitter.com/dassault_onair linkedin.com/company/dassault-aviation facebook.com/dassaultaviation Dassault Systèmes Press Contacts Corporate / France Arnaud MALHERBE arnaud.malherbe@3ds.com +33 (0)1 61 62 87 73North America Natasha LEVANTI natasha.levanti@3ds.com +1 (508) 449 8097EMEA Virginie BLINDENBERG virginie.blindenberg@3ds.com +33 (0) 1 61 62 84 21China Grace MU grace.mu@3ds.com +86 10 6536 2288India Kriti ASHOK kriti.ashok@3ds.com +91 9741310607Japan Misae HASHIDA misae.hashida@3ds.com +81 3 4321 3418Korea Jeemin JEONG jeemin.jeong@3ds.com +82 2 3271 6653AP South Minming CHEN minming.chen@3ds.com +65 6511 7931 Dassault Aviation Press Contacts Corporate/France: Stéphane Fort - Tel.: +33 (0)1 47 11 86 90 - stephane.fort@dassault-aviation.comMathieu Durand - Tel.: +33 (0)1 47 11 85 88 - mathieu.durand@dassault-aviation.com HD photos: mediaprophoto.dassault-aviation.com HD videos: mediaprovideo.dassault-aviation.com
Hyundai N returns to its home circuit at the Nürburgring, as IONIQ 5 N, N's first all-electric model, enters final testing before its world premiere IONIQ 5 N expands N's three pillars of N performance — Corner Rascal, Racetrack Capability and Everyday Sportscar — into electrified models without compromise IONIQ 5 N seeks to elevate N brand by offering a higher performance value through new technology complimented by an EV-specific experience for driving enthusiasts The high-performance EV backs motorsport-bred hardware with advanced software to ensure increased endurance, powerful braking and emotional driving excitement N brand releases its third and final teaser signaling the end of development and preparing for its global debut IONIQ 5 N to be unveiled at Goodwood Festival of Speed with exclusive N stand and hill climb demonstrations SEOUL, South Korea, June 23, 2023 /PRNewswire/ -- Hyundai Motor Company is testing the performance capabilities of IONIQ 5 N at the Nürburgring circuit for its world premiere in July. "The Nürburgring is where every N model is honed to the Nth degree, so our first high-performance, all-electric N model must also prove itself here," said Till Wartenberg, Vice President and Head of N Brand & Motorsport at Hyundai Motor Company. "IONIQ 5 N just completed its 10,000 km durability test on the Nordschleife, which is an important milestone that proves the vehicle's high endurance and racetrack capability. And yet, we just began our second 10,000 km test to push IONIQ 5 N's limits." Maximizing endurance in racetrack conditions Hyundai N brand has long used the Nürburgring Nordschleife track to validate motorsport-bred technologies on N brand vehicles. Powerful braking backed by industry-leading regenerative braking Regenerative braking from the motors provide primary braking force with hydraulic brakes providing additional braking force if necessary. Hyundai N engineers designed this unique regenerative braking system. Redefining sound and gearshift as precision driving tools Many performance enthusiasts have been outspoken about their dissatisfaction with the lack of driver feedback behind the wheel of many EVs. That's why N engineers developed N Active Sound + and N e-Shift. In conjunction with the Nürburgring test, N brand released 'Hyundai N | IONIQ 5 N Teaser – Episode 3. Reaching into the heart of car culture at Goodwood Festival of Speed IONIQ 5 N will debut at the Goodwood Festival of Speed. Hyundai Motor’s IONIQ 5 N Enters Final Phase Of Racetrack Capability Testing at Nürburgring Racing Circuit Hyundai Motor’s IONIQ 5 N Enters Final Phase Of Racetrack Capability Testing at Nürburgring Racing Circuit
Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes its second bioproduction facility and doubles its manufacturing footprint to 10,000m2, one of the largest in Europe Operation of the second facility to kick start in 2024 SEOUL, South Korea, June 23, 2023 /PRNewswire/ -- SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, successfully completed its second facility for Cell and Gene Therapies (C>) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market. Yposkesi, SK pharmteco’s commercial viral vector manufacturing subsidiary for C> in France, successfully completed the construction of its second industrial bioproduction site for C> manufacturing SK pharmteco announced on June 22nd that Yposkesi, its commercial viral vector manufacturing subsidiary for C> in France, successfully completed the construction of its second industrial bioproduction site for C> manufacturing. Yposkesi's second bioproduction site is situated in its Genopole campus, the largest biotech cluster in France. The newly completed site is a 5,000 m2 facility designed in accordance with current Good Manufacturing Practices (GMP) guidelines of the US and Europe. Together with the first bioproduction site, which is also located in the Genopole campus, Yposkesi now boasts one of Europe's largest biomanufacturing facility for C> that spans 10,000 m2. The new site specializes in the bioproduction of Adeno-associated virus (AAV) and Lentiviral Vector (LV) – the widely used viral vectors in the field of cell and gene therapies, spanning from clinical to commercial applications. Yposkesi is among only a small group of global CDMOs with decades of bioprocessing experience and expertise. It is one of the few in Europe to operate two bioproduction platforms for the most used viral vectors: Adeno Associated Virus (AAV) and Lentiviral Vector (LV). It has more experience than most players at producing viral vectors at an industrial scale. With commitments from multiple clients already secured for the second facility, the company is preparing for mass production in 2024. According to the global research firm MarketsandMarkets, the global viral vector market, estimated at $5.5 billion (KRW 7.5 trillion) in 2023 and forecast to reach $12.8 billion (KRW 16.5 trillion) by 2028, is projected to increase by a compound annual growth rate (CAGR) of approximately 18%. Yposkesi is poised to enhance its global presence due to the increasing demand for viral vectors and few cGMP-compliant facilities for large-scale production. Furthermore, Yposkesi is rapidly expanding its presence in the anti-cancer and immune cell therapy market with the introduction of LentiSure™, a CAR T-cell platform designed to optimize higher yields. The facility is designed with six USP (Upstream Process) and two DSP (Downstream Process) clean rooms. This more than triples Yposkesi's bioreactor capacity from 2,000 L to 7,000 L and reduces the turnaround on projects from 18- to 12-months. It has fill and finish capacities with semi-automated suites for a total of 12,000 vials per year. Lentivirus, a prominent viral vector utilized in gene therapy and cell-based immune anticancer drugs, has experienced a surge in demand, driven by the expanding CAR-T cell therapy* market. Yposkesi, leveraging its high-yield cell culture/harvesting capabilities and cost competitiveness, has successfully ensured exceptional quality and time to market delivery of Lentiviral Vectors. "It is with great pleasure and pride that today we open the new Yposkesi viral vector manufacturing facility," said Alain Lamproye, CEO of Yposkesi. "This twin site enables us to stay up to pace with demand by producing larger quantities of C> products approved for commercialization. The facility's state-of-the-art design will allow us, in collaboration with our clients, to manufacture advanced therapies more efficiently and cost-effectively in line with their C> pipelines and commitments, making these treatments more accessible to patients." "We anticipate Yposkesi to become a leading global Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) through the synergy achieved with the Center for Breakthrough Medicines (CBM), a US-based cell and gene therapy CDMO and a subsidiary of SK pharmteco," said Yeontae Kim, Head of the Bio Investment Center at SK Inc. In 2019, SK Inc. established SK pharmteco, a globally integrated contract development and manufacturing organization (CDMO) for pharmaceuticals. SK pharmteco operates seven production facilities and five R&D centers strategically located across the United States, Europe, and Korea. As a subsidiary of SK Inc., SK pharmteco expanded its presence in the rapidly growing biopharmaceutical industry by acquiring Yposkesi in 2021, gaining entry into the cell and gene therapy market. Furthermore, in 2022, SK pharmteco became the second largest shareholder of the Center for Breakthrough Medicines, a leading cell and gene therapy CDMO in the United States, thereby securing state-of-the-art production facilities for cell and gene therapy in both Europe and the United States. About Yposkesi Yposkesi, an SK pharmteco company, is one of Europe's largest CDMOs for viral vector manufacturing in Cell and Gene Therapies (C>). Yposkesi's 30+ years' expertise in viral vectors enables it to partner successfully with both biotech companies and big pharma in producing quality preclinical to commercial batch drug therapy products within a full-service environment. The company sustainably invests in bioprocessing innovation in order to deliver high quality gene-modified cell therapies and in vivo gene therapy projects. Yposkesi employs around 200 people and is headquartered at the Genopole Campus at Evry-Courcouronnes (South of Paris), France. www.yposkesi.com About SK pharmteco Headquartered in Rancho Cordova, California, SK pharmteco is a global CDMO and a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea's second-largest conglomerate. SK pharmteco was established in 2019 by consolidating highly complementary CDMO business operations. SK pharmteco has established a well-balanced business portfolio by engaging in small molecule & cell and gene therapy to capture both the robust and exponential growth of each market. Most recently, SK pharmteco became the second-largest shareholder of the Center for Breakthrough Medicines through its investment in March 2022. SK pharmteco currently operates seven global manufacturing sites in the United States, Europe, and South Korea, along with five R&D centers. www.skpharmteco.com Yposkesi CEO, Alain Lamproye and CEO of SK phamteco, Joerg Ahlgrimm at the Yposkesi’s completed second plant.
Venture Global set to become Germany's largest LNG supplier, with a combined 4.25MTPA of 20-year offtake agreements signed Approximately half of CP2 20MTPA nameplate capacity has been sold, with 1/3 of the contracted capacity committed to German customers Construction expected to begin in 2023 ARLINGTON, Va., June 23, 2023 /PRNewswire/ -- Today, Venture Global LNG and SEFE Securing Energy for Europe GmbH (SEFE) announced the execution of a long-term Sales and Purchase Agreement (SPA). Under the agreement, SEFE's subsidiary, WINGAS GmbH, will purchase 2.25 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from CP2 LNG, Venture Global's third project, for 20 years. "Venture Global is thrilled to begin a strategic partnership with SEFE, making our company the largest long-term LNG supplier to Germany," said Mike Sabel, CEO of Venture Global LNG. "SEFE is playing a leading role in ensuring security of energy supply for not only Germany but the rest of the European gas market. Germany has acted decisively to diversify its energy portfolio and LNG will be a vital part of that mix as it seeks to strengthen its energy security while at the same time advancing environmental progress. We are honored to support a key U.S. ally in each of these efforts." "By joining forces with Venture Global LNG, SEFE makes another important step on our mission to secure energy for German and European customers and meet the energy demand of the region. In delivering a substantial amount of the contracted capacity of CP2 LNG to European customers, we contribute to the further diversification and sustainability of the European energy supply," said Egbert Laege, CEO of SEFE. SEFE, a German state-owned company, joins other CP2 LNG customers, including ExxonMobil, Chevron, JERA, New Fortress Energy, INPEX, China Gas and EnBW. To date, 9.25MTPA of the 20MTPA nameplate capacity for CP2 has been sold with active discussions ongoing for the remaining capacity. Approximately 1/3 of the current offtake agreements are with German buyers, further underscoring the importance of CP2 LNG to Germany's long-term energy security. About Venture Global LNGVenture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global's first facility, Calcasieu Pass, commenced producing first LNG in January 2022. The company is also constructing or developing an additional 60 MTPA of production capacity in Louisiana to provide clean, affordable energy to the world. The company is developing Carbon Capture and Sequestration (CCS) projects at each of its LNG facilities. About SEFESEFE Securing Energy for Europe GmbH (SEFE) is an integrated energy company owned by the Federal Republic of Germany that is active in various stages along the value chain. Headquartered in Berlin, Germany, the company with more than 1,500 employees has its strongest presence in Germany, supplying industrial customers and municipal utilities. SEFE is a midstream company focusing on trading & portfolio management, sales, storage and pipeline infrastructure. SEFE plays a pivotal role in providing energy supply stability for Germany and Europe.
A12 藝術空間
Type-C
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
